Gene · 3978
Papers1,551
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,551
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Alteration of N6-methyladenosine modification profiles in the neutrophilic RNAs following ischemic stroke. | Neuroscience | 2024 | 38945353 | PubTator, text mining | PubMed |
| Severe Combined Immunodeficiency from a Homozygous DNA Ligase 1 Mutant with Reduced Catalytic Activity but Increased Ligation Fidelity. | J Clin Immunol | 2024 | 38896336 | PubTator, text mining | PubMed |
| The TIMELESS and PARP1 interaction suppresses replication-associated DNA gap accumulation. | Nucleic Acids Res | 2024 | 38801073 | PubTator, text mining | PubMed |
| Structural and biochemical characterization of LIG1 during mutagenic nick sealing of oxidatively damaged ends at the final step of DNA repair. | bioRxiv | 2024 | 38766188 | PubTator, text mining | PubMed |
| Therapeutic validation of MMR-associated genetic modifiers in a human ex vivo model of Huntington disease. | Am J Hum Genet | 2024 | 38749429 | PubTator, text mining | PubMed |
| Impact of DNA ligase inhibition on the nick sealing of polβ nucleotide insertion products at the downstream steps of base excision repair pathway. | Mutagenesis | 2024 | 38736258 | PubTator, text mining | PubMed |
| Impact of DNA ligase 1 and IIIα interactions with APE1 and polβ on the efficiency of base excision repair pathway at the downstream steps. | J Biol Chem | 2024 | 38718860 | PubTator, text mining | PubMed |
| Investigating Potential Cancer Therapeutics: Insight into Histone Deacetylases (HDACs) Inhibitions. | Pharmaceuticals (Basel) | 2024 | 38675404 | PubTator, text mining | PubMed |
| Uncovering nick DNA binding by LIG1 at the single-molecule level. | bioRxiv | 2024 | 38586032 | PubTator, text mining | PubMed |
| Inactive Parp2 causes Tp53-dependent lethal anemia by blocking replication-associated nick ligation in erythroblasts. | bioRxiv | 2024 | 38559022 | PubTator, text mining | PubMed |
| Structures of LIG1 provide a mechanistic basis for understanding a lack of sugar discrimination against a ribonucleotide at the 3'-end of nick DNA. | J Biol Chem | 2024 | 38522520 | PubTator, text mining | PubMed |
| FUS unveiled in mitochondrial DNA repair and targeted ligase-1 expression rescues repair-defects in FUS-linked motor neuron disease. | Nat Commun | 2024 | 38461154 | PubTator, text mining | PubMed |
| The molecular basis of cell memory in mammals: The epigenetic cycle. | Sci Adv | 2024 | 38416817 | PubTator, text mining | PubMed |
| Unfilled gaps by polβ lead to aberrant ligation by LIG1 at the downstream steps of base excision repair pathway. | Nucleic Acids Res | 2024 | 38366780 | PubTator, text mining | PubMed |
| A scalable platform for efficient CRISPR-Cas9 chemical-genetic screens of DNA damage-inducing compounds. | Sci Rep | 2024 | 38291084 | PubTator, text mining | PubMed |
| D-type cyclins regulate DNA mismatch repair in the G1 and S phases of the cell cycle, maintaining genome stability. | bioRxiv | 2024 | 38260436 | PubTator, text mining | PubMed |
| Temporal Quantitative Proteomic and Phosphoproteomic Profiling of SH-SY5Y and IMR-32 Neuroblastoma Cells during All-Trans-Retinoic Acid-Induced Neuronal Differentiation. | Int J Mol Sci | 2024 | 38256121 | PubTator, text mining | PubMed |
| Correction: hsa_circ_0007919 induces LIG1 transcription by binding to FOXA1/TET1 to enhance the DNA damage response and promote gemcitabine resistance in pancreatic ductal adenocarcinoma. | Mol Cancer | 2024 | 38229124 | PubTator, text mining | PubMed |
| The enzymatic properties of Arabidopsis thaliana DNA polymerase λ suggest a role in base excision repair. | Plant Mol Biol | 2024 | 38217735 | PubTator, text mining | PubMed |
| Replication Protein A, the Main Eukaryotic Single-Stranded DNA Binding Protein, a Focal Point in Cellular DNA Metabolism. | Int J Mol Sci | 2024 | 38203759 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3978/papers?page=5